Abstracts must be written in English, can only be submitted online through this website, should be submitted within May 31^st and must not exceed 3500 characters including blanks.

Abstracts must focus on one of the following topics:

1. In vitro and in vivo models
2. stem cells
3. Minimal residual disease
4. Oncogenic signaling
5. Next generation sequencing in APL
6. Clinical trials
7. Pathogenesis and management of coagulopathy
8. Early death, epidemiology
9. Supportive care
10. Management of Relapse
11. APL management in Developing Countries
12. APL as a second tumor and t-MN after APL
13. Pediatric and elderly APL

The Scientific Committee will select the abstracts received as:

1. accepted as a oral presentation
2. accepted as a poster presentation (70w x 100h cm)

Within July 31st 2013, the Organizing Secretariat will send a mail with the notification of acceptance for presentation or rejection, together with information about session, date and time of discussion.

Please use the "Register" link on the top to register (free of charge) yourself as the Corresponding Author; all further correspondence will then be mailed to the address you will specify within the registration form. Please remember that the presenters of an accepted (oral or poster) abstract must be also registered to the conference (with another different registration).

Plese use the "ABSTRACTS/Authors" link on the top to login.